Bolt Biotherapeutics(BOLT) - 2023 Q1 - Quarterly Report

Legal Proceedings 16 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan Performance and Service-Based Stock Options The following table summarizes the components of stock-based compensation expense recognized in the Company's statement of operations and comprehensive loss (in thousands): 17 The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common stockholders, which excludes shares which are legally outstanding, but subject to ...